Log in

NYSE:DVADavita Stock Price, Forecast & News

$81.05
+0.41 (+0.51 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$80.79
Now: $81.05
$82.68
50-Day Range
$75.56
MA: $79.93
$88.28
52-Week Range
$50.68
Now: $81.05
$90.15
Volume880,488 shs
Average Volume1.09 million shs
Market Capitalization$9.87 billion
P/E Ratio12.74
Dividend YieldN/A
Beta1.2
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services; vascular access services; clinical research programs; physician services; and comprehensive care services. As of December 31, 2018, it provided dialysis and administrative services in the United States through a network of 2,664 outpatient dialysis centers serving approximately 202,700 patients; and operated 241 outpatient dialysis centers located in 9 countries outside of the United States serving approximately 25,000 patients. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was founded in 1994 and is headquartered in Denver, Colorado.
Read More
Davita logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.1Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.27 out of 5 stars


Industry, Sector and Symbol

Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryHealth Care Services
SectorMedical
CUSIP23918K10
Phone720-631-2100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.39 billion
Cash Flow$11.27 per share
Book Value$18.10 per share

Profitability

Net Income$810.98 million

Miscellaneous

Employees65,000
Market Cap$9.87 billion
Next Earnings Date8/6/2020 (Estimated)
OptionableOptionable

Receive DVA News and Ratings via Email

Sign-up to receive the latest news and ratings for DVA and its competitors with MarketBeat's FREE daily newsletter.

Davita (NYSE:DVA) Frequently Asked Questions

How has Davita's stock been impacted by COVID-19 (Coronavirus)?

Davita's stock was trading at $74.87 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, DVA shares have increased by 8.3% and is now trading at $81.05. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Davita?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Davita in the last year. There are currently 9 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Davita.

When is Davita's next earnings date?

Davita is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Davita.

How were Davita's earnings last quarter?

Davita Inc (NYSE:DVA) released its quarterly earnings results on Tuesday, May, 5th. The company reported $1.83 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.47 by $0.36. The business had revenue of $2.84 billion for the quarter, compared to analysts' expectations of $2.84 billion. Davita had a net margin of 7.85% and a return on equity of 32.45%. Davita's revenue for the quarter was up 3.6% on a year-over-year basis. During the same period last year, the firm posted $0.91 earnings per share. View Davita's earnings history.

What guidance has Davita issued on next quarter's earnings?

Davita issued an update on its FY20 earnings guidance on Tuesday, May, 5th. The company provided earnings per share guidance of $5.75-6.25 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.01. The company issued revenue guidance of $11.5-11.7 billion, compared to the consensus revenue estimate of $11.65 billion.

What price target have analysts set for DVA?

11 brokerages have issued twelve-month price objectives for Davita's shares. Their forecasts range from $57.00 to $90.00. On average, they expect Davita's stock price to reach $68.86 in the next year. This suggests that the stock has a possible downside of 15.0%. View analysts' price targets for Davita.

Has Davita been receiving favorable news coverage?

Media stories about DVA stock have been trending negative this week, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Davita earned a news sentiment score of -2.1 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news about Davita.

Who are some of Davita's key competitors?

What other stocks do shareholders of Davita own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Davita investors own include CA (CA), BlackRock (BLK), Chipotle Mexican Grill (CMG), Endologix (ELGX), Aegean Marine Petroleum Network (ANW), Micron Technology (MU), United Rentals (URI), AutoZone (AZO), Walt Disney (DIS) and Gilead Sciences (GILD).

Who are Davita's key executives?

Davita's management team includes the following people:
  • Mr. Kent J. Thiry, Chairman & CEO (Age 63)
  • Mr. Joel Ackerman, Chief Financial Officer (Age 54)
  • Mr. James K. Hilger, Chief Accounting Officer (Age 57)
  • Ms. Kathleen Alyce Waters, Chief Legal Officer (Age 51)
  • Mr. Javier J. Rodriguez, Chief Exec. Officer of DaVita Kidney Care (Age 48)

What is Davita's stock symbol?

Davita trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."

How do I buy shares of Davita?

Shares of DVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Davita's stock price today?

One share of DVA stock can currently be purchased for approximately $81.05.

How big of a company is Davita?

Davita has a market capitalization of $9.87 billion and generates $11.39 billion in revenue each year. The company earns $810.98 million in net income (profit) each year or $5.40 on an earnings per share basis. Davita employs 65,000 workers across the globe.

What is Davita's official website?

The official website for Davita is www.davita.com.

How can I contact Davita?

Davita's mailing address is 2000 16TH STREET, DENVER CO, 80202. The company can be reached via phone at 720-631-2100 or via email at [email protected]

This page was last updated on 7/6/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.